Skip to main content

Day: January 8, 2026

11:11 Systems Successfully Completes Acquisition of Ntirety

Acquisition marks the sixth purchase of an authorised VMware partner for 11:11 Systems, now one of the largest private VMware Cloud Service Provider partners   AMSTERDAM – January 8, 2026 11:11 Systems (“11:11”), a leading managed infrastructure provider, today announced the acquisition of Ntirety, a managed and professional IT services firm.   Recent changes made by Broadcom to the VMware Cloud Service Provider (“VCSP”) ecosystem have optimised the number of authorised VMware partners. This has led former VCSPs to choose the best approach for them to assure their customers have ongoing access to VMware cloud infrastructure. Options include creating new partnerships, migrating or joining forces with a VCSP.    “11:11 has been actively working with many former VCSPs to guarantee secure, compliant, high-performing cloud services and determine...

Continue reading

11:11 Systems Successfully Completes Acquisition of Ntirety

Acquisition marks the sixth purchase of an authorised VMware partner for 11:11 Systems, now one of the largest private VMware Cloud Service Provider partners   LONDON – January 8, 2026 11:11 Systems (“11:11”), a leading managed infrastructure provider, today announced the acquisition of Ntirety, a managed and professional IT services firm.   Recent changes made by Broadcom to the VMware Cloud Service Provider (“VCSP”) ecosystem have optimised the number of authorised VMware partners. This has led former VCSPs to choose the best approach for them to assure their customers have ongoing access to VMware cloud infrastructure. Options include creating new partnerships, migrating or joining forces with a VCSP.    “11:11 has been actively working with many former VCSPs to guarantee secure, compliant, high-performing cloud services and determine...

Continue reading

Clearway Energy Operating LLC, a Subsidiary of Clearway Energy, Inc., Announces Proposed Offering of $500 Million of Senior Notes

PRINCETON, N.J., Jan. 08, 2026 (GLOBE NEWSWIRE) — Clearway Energy Operating LLC (“Clearway Operating”), a subsidiary of Clearway Energy, Inc. (NYSE: CWEN, CWEN.A) (“Clearway Energy”), today announced that, subject to market conditions, it intends to commence an offering of $500 million in aggregate principal amount of senior notes due 2034 (the “New Notes”). The New Notes will be senior unsecured obligations of Clearway Operating and will be guaranteed by Clearway Energy LLC, Clearway Operating’s parent company, and by each of Clearway Operating’s wholly owned current and future subsidiaries that guarantees indebtedness under its credit agreement. Clearway Operating intends to allocate an amount equal to the net proceeds from the offering of the New Notes to finance or refinance certain indebtedness, in part or in full, and acquire...

Continue reading

Diana Shipping Inc. Announces Direct Continuation of Time Charter Contract for m/v Maia with Paralos Shipping

ATHENS, Greece, Jan. 08, 2026 (GLOBE NEWSWIRE) — Diana Shipping Inc. (NYSE: DSX), (the “Company”), a global shipping company specializing in the ownership and bareboat charter-in of dry bulk vessels, today announced that, through a separate wholly-owned subsidiary, it has entered into a time charter contract with Paralos Shipping Pte. Ltd., for one of its Kamsarmax dry bulk vessels, the m/v Maia. The gross charter rate is US$14,000 per day, minus a 5.00% commission paid to third parties, for a period until minimum July 5, 2027 up to maximum September 5, 2027. The new charter period is expected to commence on January 13, 2026. The m/v Maia is currently chartered, as previously announced, at a gross charter rate of US$11,600 per day, minus a 5.00% commission paid to third parties. The “Maia” is an 82,193 dwt Kamsarmax dry bulk vessel...

Continue reading

CHINA SXT PHARMACEUTICALS, INC. ANNOUNCES STRATEGIC AI INSIGHTS INITIATIVE TO OPTIMIZE TRADITIONAL CHINESE MEDICINE PORTFOLIO, ENHANCE MARKET ANALYSIS AND EXPLORE AI-SUPPORTED CLINIC DEPLOYMENT

TAIZHOU, China, Jan. 08, 2026 (GLOBE NEWSWIRE) — China SXT Pharmaceuticals, Inc. (NASDAQ: SXTC) (“China SXT” or the “Company”), a specialty pharmaceutical company focusing on the research, development, manufacturing, marketing, and sales of Traditional Chinese Medicine Pieces (“TCMPs”), including Advanced TCMPs (Directly-Oral TCMP and After-Soaking-Oral TCMP), fine TCMPs, regular TCMPs, and TCM Homologous Supplements (“TCMHS”), today announced the launch of a Strategic Artificial Intelligence (AI) Insights Initiative. This initiative aims to integrate AI-driven analytics into the Company’s product portfolio planning and market intelligence processes, further strengthening its long-term strategy to evolve into a data-informed and innovation-driven modern TCM enterprise. The primary...

Continue reading

ECD Automotive Design Enters into Discussions to Improve its Shareholder Equity Position

KISSIMMEE, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) — ECD Automotive Design, Inc. (“ECD” or the “Company”) (NASDAQ: ECDA), the world’s largest Land Rover and Jaguar restoration company known for its custom luxury builds, including bespoke Defenders, Range Rovers, Jaguar E-Types, Ford Mustangs, and Toyota FJs, today announced that on January 6, 2026, a lender to ECD entered into discussions with the Company concerning pursuing various strategic transactions with the Company valued between $2 million and $10 million for a combination of cash and preferred stock, which are expected to close within the next 30 days and/or a debt to preferred equity exchange valued between $2 million and $10 million with the current lender to help the Company improve its Shareholder Equity position. About ECD Auto Design ECD, a public company trading under...

Continue reading

Global AI Secures Agentic AI Platform Contract with Major Automobile Dealership within the European Region

AI-powered workflow platform to optimize operations across numerous dealership locations New York, Jan. 08, 2026 (GLOBE NEWSWIRE) — Global AI Inc. (OTC: GLAI), a leader in enterprise artificial intelligence (AI), agentic products and solutions, today announced that it has secured an important contract for its agentic AI platform with a major automobile dealership group operating in numerous locations across the European region. The dealership plans deploy Global AI’s agentic AI platform to modernize its operational infrastructure, enhance customer experience, and drive enterprise-wide efficiency. As most enterprises struggle with inefficiencies buried in outdated systems and manual workflows, Global AI’s agentic AI platform identifies these gaps and rebuilds processes for speed, accuracy, and compliance. The Global AI platform...

Continue reading

Akari Therapeutics to Present at the 2026 Biotech Showcase

In-person presentation on Tuesday, January 13th at 9:30 AM PT As part of the presentation, Mr. Gaslightwala will provide an overview of Akari’s ADC platform, strategic priorities and key milestones for 2026 TAMPA, Fla. and LONDON, Jan. 08, 2026 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an oncology biotechnology company developing antibody drug conjugates (ADCs) with novel payloads, today announced that Abizer Gaslightwala, President and Chief Executive Officer of Akari Therapeutics will present at the 2026 Biotech Showcase being held from January 12-14, 2026 in San Francisco, CA. Presentation details are as follows: Date/Time: Tuesday, January 13, 2026 at 9:30 AM PSTLocation: Yosemite A (Ballroom Level) In addition to the presentation, management will be available to participate in in-person one-on-one meetings...

Continue reading

Kratos Applauds Focus on Reinvestment to Strengthen Defense Readiness

SAN DIEGO, Jan. 08, 2026 (GLOBE NEWSWIRE) — Kratos Defense & Security Solutions, Inc. (NASDAQ: KTOS), a leader in defense, national security and global markets, today expressed strong support for President Trump’s announcement of policies that prioritize reinvestment in national defense capabilities over stock buybacks by defense contractors. Kratos has long operated under a fundamentally different capital allocation philosophy than much of the publicly traded defense market. The company does not have a practice of conducting stock buybacks or paying dividends, choosing instead to reinvest capital directly into the development, production, and fielding of affordable, mission-ready technologies for the warfighter. “At Kratos, every dollar we earn is viewed through the lens of readiness and capability,” said Eric DeMarco, President...

Continue reading

Genelux Corporation Announces Pricing of $20.0 Million Underwritten Public Offering of Common Stock

WESTLAKE VILLAGE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) — Genelux Corporation (“Genelux”) (Nasdaq: GNLX), a late clinical-stage immuno-oncology company, today announced the pricing of an underwritten public offering of 6,666,667 shares of its common stock at a price to the public of $3.00 per share. All of the shares in the offering are to be sold by Genelux. The gross proceeds to Genelux from the offering are expected to be approximately $20.0 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by Genelux. In addition, Genelux has granted the underwriter a 30-day option to purchase up to an additional 1,000,000 shares of its common stock at the price to the public, less underwriting discounts and commissions. The net proceeds from the offering are expected to be used for general...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.